BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9021661)

  • 1. [A 26-week oral repeated dose toxicity study of a new antineoplastic agent S-1 in rats].
    Hakoi K; Hayashi T; Ohmae S; Besshi K
    J Toxicol Sci; 1996 Nov; 21 Suppl 3():545-60. PubMed ID: 9021661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A 13-week oral repeated dose toxicity study of a new antineoplastic agent S-1 in rats].
    Hayashi T; Hasegawa H; Tanaka G; Ohmae S
    J Toxicol Sci; 1996 Nov; 21 Suppl 3():505-26. PubMed ID: 9021659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An oral repeated dose toxicity study of a new antineoplastic agent S-1 in dogs. I. A 13-week repeated dose toxicity study. II. An ophthalmologic toxicity recovery study].
    Hayashi T; Yamaguchi S; Kito S; Tanaka G; Kurokawa K; Hirota T
    J Toxicol Sci; 1996 Nov; 21 Suppl 3():527-44. PubMed ID: 9021660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A 52-week oral toxicity study of a new antineoplastic agent S-1 in dogs].
    Kitajima S; Okamura T; Kobayashi K; Watari N; Inoue H; Enomoto M; Yamaguchi S
    J Toxicol Sci; 1996 Nov; 21 Suppl 3():561-88. PubMed ID: 9021662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oral single-dose toxicity study of a new antineoplastic agent S-1, and its components, CDHP, and Oxo].
    Hayashi T; Tanaka G; Irimura K; Hirota T; Ohmae S
    J Toxicol Sci; 1996 Nov; 21 Suppl 3():495-504. PubMed ID: 9021658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reproductive and developmental toxicity study of a new antineoplastic agent, S-1 (I)--Fertility study in rats by oral administration].
    Shinomiya M; Imamura K; Izumi K
    J Toxicol Sci; 1996 Nov; 21 Suppl 3():589-602. PubMed ID: 9021663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reproductive and developmental toxicity study of a new antineoplastic agent, S-1 (IV)--Perinatal and postnatal study in rats by oral administration].
    Furuhashi T; Kato M; Fujimura T; Koida M
    J Toxicol Sci; 1996 Nov; 21 Suppl 3():643-59. PubMed ID: 9021666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reproductive and developmental toxicity study of a new antineoplastic agent, S-1 (III)--Teratological study in rabbits by oral administration].
    Shinomiya M; Yukiyama S; Ikebuchi K
    J Toxicol Sci; 1996 Nov; 21 Suppl 3():619-41. PubMed ID: 9021665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reproductive and developmental toxicity study of a new antineoplastic agent, S-1 (II)--Teratological study in rats by oral administration].
    Yukiyama S; Shinomiya M; Ikebuchi K; Sato T
    J Toxicol Sci; 1996 Nov; 21 Suppl 3():603-18. PubMed ID: 9021664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunotoxic effects of a new antineoplastic agent S-1 in mice--comparison with S-1, UFT and 5-FU].
    Kouchi Y; Maeda Y; Morinaga H; Ohuchida A
    J Toxicol Sci; 1996 Nov; 21 Suppl 3():691-701. PubMed ID: 9021669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mutagenicity study of a new antineoplastic agent S-1, and its components, CDHP, and Oxo].
    Ohuchida A; Kouchi Y; Sato S; Maeda Y
    J Toxicol Sci; 1996 Nov; 21 Suppl 3():675-89. PubMed ID: 9021668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antigenicity tests of a new antineoplastic agent S-1].
    Maeda Y; Morinaga H; Izumi K; Ikebuchi K; Kouchi Y
    J Toxicol Sci; 1996 Nov; 21 Suppl 3():661-73. PubMed ID: 9021667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased intestinal permeability correlates with gastrointestinal toxicity among formulations of the fluorouracil analogue tegafur in rats.
    Korenaga D; Honda M; Yasuda M; Inutsuka S; Nozoe T; Tashiro H
    Eur Surg Res; 2002; 34(5):351-6. PubMed ID: 12364819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP Toxicology and Carcinogenesis Studies of 1,4-Dichlorobenzene (CAS No. 106-46-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1987 Jan; 319():1-198. PubMed ID: 12748734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicology and carcinogenesis studies of N,N-dimethyl-p-toluidine (CAS No. 99-97-8) in F344/N rats and B6C3F1/N mice (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2012 Sep; (579):1-211. PubMed ID: 23027199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients.
    Sakata Y; Ohtsu A; Horikoshi N; Sugimachi K; Mitachi Y; Taguchi T
    Eur J Cancer; 1998 Oct; 34(11):1715-20. PubMed ID: 9893658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of p-Nitrobenzoic Acid (CAS No. 62-23-7) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 442():1-306. PubMed ID: 12595921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diamine oxidase, a plasma biomarker in rats to GI tract toxicity of oral fluorouracil anti-cancer drugs.
    Moriyama K; Kouchi Y; Morinaga H; Irimura K; Hayashi T; Ohuchida A; Goto T; Yoshizawa Y
    Toxicology; 2006 Jan; 217(2-3):233-9. PubMed ID: 16278042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New oral anticancer drug, TS-1 (S-1)--from bench to clinic].
    Shirasaka T; Tsukuda M; Inuyama Y; Taguchi T
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):855-64. PubMed ID: 11432358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.